Fibrocystic Breasts Diagnostics and Treatment Market Highlights
The fibrocystic breasts diagnostics and treatment market share report expects the industry to register the value worth USD 24.67 Billion by 2030 at a CAGR 7.90% significant growth during the forecast period (2023–2030).
Fibrocystic breasts are a non-cancerous disease characterized by round lumps which move freely within the breast tissue and normally swell and shrink with the onset and end of the menstrual cycle. It is projected that 40% of all women in North America are suffering from fibrocystic breast disease. Fibrocystic breast changes are common in women of ages 20- 50. Drinking alcohol may increase the risk of having fibrocystic breast, especially in young women between 18 to 22 years of age. The symptoms are lumps, cyclic breast pain, tenderness, and nipple discharge.
Moreover, restrains for the market includes the high cost of the surgical procedure and the risks involved in the procedures are likely to affect the global fibrocystic breasts diagnostics and treatment negatively.
Segmentation
The global fibrocystic breasts diagnostics and treatment market has been segmented into type and end users. On the basis of type, the market has been classified as diagnosis and treatment. The diagnosis is segmented into mammogram and breast biopsy. The treatment is segmented into medications, fine-needle aspiration, surgical excision, oral contraceptives. The medications are further segmented into acetaminophen, nonsteroidal anti-inflammatory drugs. On the basis of end users, the market has been classified as hospitals, clinics, diagnostic centers, specialty clinics and rehab centers, research institutes, and others.
Regional Analysis
The Americas is projected to lead the fibrocystic breasts diagnostics and treatment market in the forecast period. Rising rate in a number of surgeries due to increasing healthcare awareness, advancement in technology, medical tourism, and the increase in disposable income are some other factors that boost the growth of the market. A widespread number of women, over 90% in some form have estrogen and progesterone levels disturbance. According to the National Institute of Mental Health (NIMH), variations in estrogen activates uncharacteristic functioning in the crucial brain memory circuit in women with a mutual version of the gene. Brain scans helped to discover that altered circuit activity is linked to changes in the sex hormone in women with the gene variant while women are performing a working memory task.
The European market is expected to hold the second largest market share as fibrocystic breasts diagnostics and treatment market is most common in Germany. The European market is projected to grow because of increase in the elderly population, growing prevalence of diabetes, and obesity in the region.
Asia-Pacific was projected to be the fastest growing region for the global fibrocystic breast diagnostics and treatment market in 2018. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow.
The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.
Key Players
Some of the top key players profiled in the fibrocystic breast diagnostics and treatment market trends report are Argon Medical Devices, Boston Scientific, CareFusion Corporation (Acquired by Becton, Dickinson and Company), C. R. Bard, Inc, Cook Medical, Devicor Medical Products Inc., Gallini Medical Devices, Hologic, Inc., INRAD, Inc., Merck Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd, Bayer AG, and Allergan plc.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
